Compare Celestica Inc (CLS) vs Citius Pharmaceuticals Inc (CTXR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Celestica Inc vs Citius Pharmaceuticals Inc — how do they compare? Celestica Inc trades at $319.41 (market cap $39.16B), while Citius Pharmaceuticals Inc trades at $0.73 (market cap $20.01M). The key difference: Celestica Inc is far larger — about 1957× Citius Pharmaceuticals Inc's market cap, and Celestica Inc is trading nearer its 52-week high, Citius Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| CLS | CTXR | |
|---|---|---|
Market Cap | $39.16B | $20.01M |
Sector | Technology | Health |
52-Week High | $472.40 | $1.82 |
52-Week Low | $181.34 | $0.48 |
Enterprise Value | $39.44B | $16.23M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Celestica Inc
Celestica provides supply chain and manufacturing solutions for global technology companies. It specializes in high-complexity assembly and platform solutions for AI data centers, aerospace, and medical markets.
Read more on CLS →About Citius Pharmaceuticals Inc
Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Read more on CTXR →
